NU 18I03 - Pilot Study of Nivolumab in Combination with Therasphere (yttrium-90) for Treatment of Hepatocellular Carcinoma (HCC) with Intent for Resection

Project: Research project

Project Details

StatusActive
Effective start/end date1/8/191/8/22

Funding

  • Bristol-Myers Squibb Company (NU 18I03)